Tadalafil - PDFSEARCH.IO - Document Search Engine

Tadalafil
Results: 187

#	Item
151	HIGHLIGHTS OF PRESCRIBING INFORMATION • These highlights do not include all the information needed to use ADCIRCA safely and effectively. See full prescribing information Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-04-30 17:40:12 Eli Lilly and Company PDE5 inhibitors Tadalafil Organochlorides Amines CGMP-specific phosphodiesterase type 5 Pulmonary hypertension Phosphodiesterase inhibitor Methadone Lactams Chemistry Organic chemistry
152	CHF / Pulmonary Edema History Signs and Symptoms Differential Add to Reading List Source URL: www.ncems.org Language: English - Date: 2013-01-10 08:38:59 Medical emergencies Lactams PDE5 inhibitors Heart diseases Aging-associated diseases Pulmonary edema Sildenafil Heart failure Tadalafil Medicine Organic chemistry Chemistry
153	Chest Pain: Cardiac and STEMI History · · · · Add to Reading List Source URL: www.ncems.org Language: English - Date: 2013-01-10 08:39:33 Lactams PDE5 inhibitors Piperazines Medical emergencies Aging-associated diseases Tadalafil Sildenafil Vardenafil Myocardial infarction Organic chemistry Chemistry Medicine
154	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading List Source URL: www.fda.gov Language: English Immunosuppressants Lactams PDE5 inhibitors Eli Lilly and Company Piperazines Infliximab Exenatide Tadalafil Sildenafil Medicine Chemistry Organic chemistry
155	1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIALIS safely and effectively. See full prescribing information for CIALIS. CIALIS (tadalafil) tablets, for oral u Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-04-30 17:40:11 Chemistry Eli Lilly and Company Tadalafil CGMP-specific phosphodiesterase type 5 Finasteride Erectile dysfunction Benign prostatic hyperplasia Vardenafil Sildenafil Lactams PDE5 inhibitors Organic chemistry
156	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ADEMPAS safely and effectively. See full prescribing information for ADEMPAS. Adempas (riociguat) tablets, for oral Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-05-09 14:51:40 PDE5 inhibitors Alcohols Organochlorides Pyrimidines Riociguat Sildenafil Tadalafil Pulmonary hypertension Oxazepam Chemistry Organic chemistry Lactams
157	• HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIRACEPT safely and effectively. See full prescribing information for VIRACEPT. Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-06-04 11:53:45 Piperazines Protease inhibitors PDE5 inhibitors Pfizer Nelfinavir Trazodone Norfloxacin Sildenafil Tadalafil Chemistry Organic chemistry Lactams
158	DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Rockville MD[removed]SEP Add to Reading List Source URL: www.fda.gov Language: English Clinical research Food law Clinical pharmacology Food and Drug Administration Therapeutics United States Public Health Service Advertising Tadalafil Title 21 of the Code of Federal Regulations Medicine Pharmaceutical sciences Pharmacology
159	LEVITRA® (vardenafil HCl) TABLETS[removed]DESCRIPTION Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:45:49 Lactams Piperazines GlaxoSmithKline Sulfones Vardenafil CGMP-specific phosphodiesterase type 5 Erectile dysfunction Amiodarone Tadalafil Chemistry Organic chemistry PDE5 inhibitors
160	CIALIS® 1 ANL 5215 AMP (tadalafil) Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:45:47 Organic chemistry Lactams PDE5 inhibitors Tadalafil Amines CGMP-specific phosphodiesterase type 5 Clinical research Erectile dysfunction Placebo Chemistry Eli Lilly and Company Medicine

UPDATE